Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer
Clinical trial NCT06249854 · COMPLETED
Trial details
- NCT number
- NCT06249854
- Sponsor
- Korea Institute of Oriental Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-08
- Primary completion
- 2025-12-02
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.